IL1B and type 2 diabetes mellitus: These data indicated that T cells in type 2 diabetes rats are naturally skewed toward proinflammatory subsets and can alleviate chronic inflammation in type 2 diabetes by reducing inflammatory cytokines, such as TNF-α, IL-1β, and IL-6 (Fig. 6J to L).